Analysis of surface electrocardiograms in atrial fibrillation: Techniques, research, and clinical applications

Europace

Volumn 8, Issue 11, 2006, Pages 911-926

  Bollmann, Andreas ^a   Husser, Daniela ^a   Mainardi, Luca ^b   Lombardi, Federico ^c   Langley, Philip ^d   Murray, Alan ^d   Rieta, José Joaquín ^e   Millet, José ^e   Olsson, S Bertil ^f   Stridh, Martin ^f   Sörnmo, Leif ^f  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b POLITECNICO DI MILANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Ablation; Antiarrhythmic drug monitoring; Atrial fibrillation; Cardioversion; ECG signal processing; Electrical remodelling

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BEPRIDIL; CIBENZOLINE; FLECAINIDE; IBUTILIDE; METOPROLOL; PROCAINAMIDE; SOTALOL;

AUTONOMIC NERVOUS SYSTEM; CARDIOVERSION; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG RESPONSE; ELECTROMYOGRAPHY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART RATE VARIABILITY; HUMAN; NON INVASIVE MEASUREMENT; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; RR INTERVAL; SPECTROSCOPY;

ATRIAL FIBRILLATION; BIOMEDICAL RESEARCH; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33750418673     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul113     Document Type: Review

References (112)

1. Fuster V, Rydén LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001;104:2118-50.
2. Bollmann A. Quantification of electrical remodeling in human atrial fibrillation. Cardiovasc Res 2000;47:207-9.
3. Bollmann A. First comes diagnosis then comes treatment: An underappreciated paradigm in atrial fibrillation management. Eur Heart J 2005;26:2487-9.
4. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-68.
5. Kim KB, Rodefeld MD, Schuessler RB, Cox JL, Boineau JP. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation 1996;94:2961-7.
6. Ramdat Misier AR, Opthof T, van Hemel NM et al. Increased dispersion of refractoriness in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 1992;19:1531-5.
7. Capucci A, Biffi M, Boriani G et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995;92:1193-202.
8. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-80.
9. Asano Y, Saito J, Matsumoto K, Kaneko K, Yamamoto T, Uchida M. On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol 1992;69:1033-8.
10. Boahene KA, Klein GJ, Yee R, Sharma AD, Fujimura O. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: Importance of atrial fibrillatory cycle length. J Am Coll Cardiol 1990;16:1408-14.
11. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: Electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96:4298-306.
12. Fujiki A, Nagasawa H, Sakabe M et al. Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. Jpn Circ J 2001;65:1047-51.
13. Attuel P, Childers R, Cauchemez B, Poveda J, Mugica J, Coumel P. Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability. Int J Cardiol 1982;2:179-97.
14. Manios EG, Kanoupakis EM, Chlouverakis GI, Kaleboubas MD, Mavrakis HE, Vardas PE. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: Relation with recurrence. Cardiovasc Res 2000;47:244-53.
15. Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart 2002;87:443-8.
16. Holm M, Pehrson S, Ingemansson M et al. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: Introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998;38:69-81.
17. Bollmann A, Kanuru NK, McTeague KK, Walter PF, DeLurgio DB, Langberg J.J. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998;81:1439-45.
18. Rosenbaum DS, Cohen RJ. Frequency based measures of atrial fibrillation in man. IEEE-EMBS 1990;12:582-3.
19. Slocum J, Sahakian A, Swiryn S. Diagnosis of atrial fibrillation from surface electrocardiograms based on computer-detected atrial activity. J Electrocardiol 1992;25:1-8.
20. Bollmann A, Binias KH, Toepffer I, Molling J, Geller C, Klein HU. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide. Am J Cardiol 2002;90:1011-4.
21. Bollmann A, Husser D, Stridh M et al. Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making. J Cardiovasc Electrophysiol 2003;14:S154-61.
22. Bollmann A, Husser D, Steinert R et al. Echo- and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2003;14:S162-5.
23. Waktare JE, Gallagher MM, Murtagh AM, Camm AJ, Malik M. Optimum lead positioning for recording bipolar atrial electrocardiograms during sinus rhythm and atrial fibrillation. Clin Cardiol 1998;21:825-30.
24. Laguna P, Sörnmo L. Sampling rate and the estimation of ensemble variability for repetitive signals. Med Biol Eng Comput 2000;38:540-6.
25. Sörnmo L, Laguna P. Bioelectrical Signal Processing in Cardiac and Neurological Applications. Amsterdam: Elsevier; 2005.
26. Slocum J, Byrom E, McCarthy L, Sahakian A, Swiryn S. Computer detection of atrioventricular dissociation from surface electrocardiograms during wide QRS complex tachycardias. Circulation 1985;72:1028-36.
27. Stridh M, Sörnmo L. Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation. IEEE Trans Biomed Eng 2001;48:105-11.
28. Raine D, Langley P, Murray A, Dunuwille A, Bourke JP. Surface atrial frequency analysis in patients with atrial fibrillation: A tool for evaluating the effects of intervention. J Cardiovasc Electrophysiol 2004; 15:1021-6.
29. Rieta JJ, Castells F, Sanchez C, Zarzoso V, Millet J. Atrial activity extraction for atrial fibrillation analysis using blind source separation. IEEE Trans Biomed Eng 2004;51:1176-86.
30. Langley P, Stridh M, Rieta JJ, Millet Roig J, Sörnmo L, Murray A. - Comparison of three atrial rhythm extraction techniques for the detection of the main atrial frequency from the 12-lead ECG in atrial fibrillation. IEEE Trans Biomed Eng 2006;53:343-6.
31. Castells F, Mora C, Rieta JJ, Moratal-Përez D, Millet J. Estimation of atrial fibrillatory wave from single-lead atrial fibrillation electrocardiograms using principal component analysis concepts. Med Biol Eng Comput 2005;43:557-60.
32. Sassi R, Mainardi LT, Maison-Blanche P, Cerruti S. Estimation of spectral parameters of residual ECG signals during atrial fibrillation using autoregressive models. Folia Cardiologica 2005;12:108-10.
33. Pehrson S, Holm M, Meurling C et al. Non-invasive assessment of magnitude and dispersion of atrial cycle length during chronic atrial fibrillation in man. Eur Heart J 1998;19:1836-44.
34. Stridh M, Sörnmo L, Meurling CJ, Olsson SB. Characterization of atrial fibrillation using the surface ECG: Time-dependent spectral properties. IEEE Trans Biomed Eng 2001;48:19-27.
35. Stridh M, Sörnmo L, Meurling CJ, Olsson SB. Sequential characterization of atrial tachyarrhythmias based on ECG time-frequency analysis. IEEE Trans Biomed Eng 2004;51:100-14.
36. Slocum JE, Ropella KM. Correspondence between the frequency domain characteristics of simultaneous surface and intra-atrial recordings of atrial fibrillation. IEEE Comput Cardiol 1994;21:781-4.
37. Lin YJ, Tai CT, Kao T et al. Electrophysiological characteristics and catheter ablation in patients with paroxysmal right atrial fibrillation. Circulation 2005;112:1692-700.
38. Husser D, Stridh M, Sörnmo L et al. Relation of pulmonary venous fibrillatory rates to rates obtained from the surface electrocardiogram in persistent atrial fibrillation. IEEE Comput Cardiol 2004;31:241-4.
39. Xi Q, Sahakian AV, Swiryn S. The effect of QRS cancellation on atrial fibrillatory wave signal characteristics in the surface electrocardiogram. J Electrocardiol 2003;36:243-49.
40. Holm M, Johansson R, Brandt J, Luhrs C, Olsson SB. Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread - a hitherto unrecognised phenomenon in man. Eur Heart J 1997;18:290-310.
41. Meurling CJ, Ingemansson MP, Roijer A et al. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999;1:234-41.
42. Xi Q, Sahakian AV, Ng J, Swiryn S. Atrial fibrillatory wave characteristics on surface electrogram: ECG to ECG repeatability over twenty-four hours in clinically stable patients. J Cardiovasc Electrophysiol 2004;15:911-17.
43. Saoudi N, Cosio F, Waldo A et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. Eur Heart J 2001;22:1162-82.
44. Bollmann A, Husser D, Olsson SB. Atrial fibrillatory frequency, atrial fibrillatory rate or atrial cycle length-does it matter? Am J Cardiol 2004;94:147.
45. Prystowsky EN, Naccarelli GV, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol 1983;51:96-100.
46. Shimizu W, Tsuchioka Y, Karakawa S et al. Differential effect of pharmacological autonomic blockade on some electrophysiological properties of the human ventricle and atrium. Br Heart J 1994;71:34-7.
47. Leitch JW, Basta M, Fletcher PJ. Effect of phenylephrine infusion on atrial electrophysiological properties. Heart 1997;78:166-70.
48. Cinca J, Moya A, Figueras J, Roma F, Rius J. Circadian variations in the electrical properties of the human heart assessed by sequential bedside electrophysiologic testing. Am Heart J 1986;112:315-21.
49. Huikuri HV, Yli-Mayry S, Linnaluoto MK, Ikaheimo MJ. Diurnal fluctuations in human ventricular and atrial refractoriness. Pacing Clin Electrophysiol 1995;18:1362-8.
50. Bollmann A, Sonne K, Esperer HD, Toepffer I, Klein HU. Circadian variations in atrial fibrillatory frequency in persistent human atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1867-71.
51. Meurling CJ, Waktare JE, Holmqvist F et al. Diurnal variations of the dominant cycle length of chronic atrial fibrillation. Am J Physiol Heart Circ Physiol 2001;280:H401-6.
52. Bollmann A, Wodarz K, Esperer HD, Toepffer I, Klein HU. Response of atrial fibrillatory activity to carotid sinus massage in patients with atrial fibrillation. Pacing Clin Electrophysiol 2001;24:1363-8.
53. Ingemansson MP, Holm M, Olsson SB. Autonomic modulation of the atrial cycle length by the head up tilt test: Non-invasive evaluation in patients with chronic atrial fibrillation. Heart 1998;80:71-6.
54. Stridh M, Meurling C, Olsson SB, Sörnmo L. Detection of autonomic modulation in permanent atrial fibrillation. Med Biol Eng Comput 2003;41:625-9.
55. Holmqvist F, Stridh M, Waktare JE et al. Rapid fluctuations in atrial fibrillatory electrophysiology detected during controlled respiration. Am J Physiol Heart Circ Physiol 2005;289:H754-60.
56. Bollmann A, Sonne K, Esperer HD, Toepffer I, Langberg JJ, Klein HU. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. Cardiovasc Res 1999;44:60-6.
57. Fujiki A, Sakabe M, Nishida K, Mizumaki K, Inoue H. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation-spectral analysis of fibrillation waves from surface electrocardiogram. Circ J 2003;67:391-5.
58. Nilsson F, Stridh M, Bollmann A, Sörnmo L. Predicting spontaneous termination of atrial fibrillation using the surface ECG. Med Eng Phys 2006;28:802-8.
59. Wijffels MC, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 2000;102:260-7.
60. Husser D, Stridh M, Sörnmo L, Platonov P, Olsson SB, Bollmann A. Analysis of the surface electrocardiogram for monitoring and predicting anti-arrhythmic drug effects in atrial fibrillation. Cardiovasc Drugs Ther 2004;18:377-86.
61. Husser D, Stridh M, Sörnmo L et al. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation. Am J Cardiol 2005;95:526-8.
62. Husser D, Binias KH, Stridh M et al. Non-invasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram. Ann Noninvas Electrocardiol 2005;10:206-10.
63. Fujiki A, Tsuneda T, Sugao M, Mizumaki K, Inoue H. Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. Am J Cardiol 2003;92:472-5.
64. Schwartz RA, Langberg JJ. Atrial electrophysiological effects of ibutilide infusion in humans. Pacing Clin Electrophysiol 2000;23:832-6.
65. Tieleman RG, Van Gelder IC, Crijns HJ et al. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-73.
66. Lombardi F, Colombo A, Basilico B et al. Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol 2001;37:157-62.
67. Everett IV TH, Li H, Mangrum JM et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000;102:1454-60.
68. Bollmann A, Mende M, Neugebauer A, Pfeiffer D. Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2002;25:1179-84.
69. Langberg JJ, Burnette JC, McTeague KK. Spectral analysis of the electrocardiogram predicts recurrence of atrial fibrillation after cardioversion. J Electrocardiol 1998;31(Suppl.):80-4.
70. Tai CT, Chen SA, Liu AS et al. Spectral analysis of chronic atrial fibrillation and its relation to minimal defibrillation energy. Pacing Clin Electrophysiol 2002;25:1747-51.
71. Raine D, Langley P, Murray A, Furniss SS, Bourke JP. Surface atrial frequency analysis in patients with atrial fibrillation: Assessing the effects of linear left atrial ablation. J Cardiovasc Electrophysiol 2005;16:838-44.
72. Haïssaguerre M, Sanders P, Hocini M et al. Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 2004;109:3007-13.
73. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
74. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
75. Chen SA, Tai CT. Is analysis of fibrillatory waves useful for treatment of atrial fibrillation? J Cardiovasc Electrophysiol 2004;15:918-9.
76. Wood MA. Ventricular rate control as an endpoint for treatment of atrial fibrillation. Heart Rhythm 2004;1:B45-51.
77. Hayano J, Sakata S, Okada A, Mukai S, Fujinami T. Circadian rhythms of atrioventricular conduction properties in chronic atrial fibrillation with and without heart failure. J Am Coll Cardiol 1998;31:158-66.
78. Friedman HS. Heart rate variability in atrial fibrillation related to left atrial size. Am J Cardiol 2004;93:705-9.
79. van den Berg MP, Haaksma J, Brouwer J, Tieleman RG, Mulder G, Crijns HJ. Heart rate variability in patients with atrial fibrillation is related to vagal tone. Circulation 1997;96:1209-16.
80. Herweg B, Dalal P, Nagy B, Schweitzer P. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol 1998;82:869-74.
81. Dimmer C, Tavernier R, Gjorgov N, Van Nooten G, Clement DL, Jordaens L. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998;82:22-5.
82. Wen ZC, Chen SA, Tai CT, Huang JL, Chang MS. Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter. J Am Coll Cardiol 1998;31:602-7.
83. Tomoda Y, Uemura S, Fujimoto S et al. Assessment of autonomic nervous activity before the onset of paroxysmal atrial fibrillation. J Cardiol 1998;31:11-7.
84. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105:2753-9.
85. Lombardi F, Tarricone D, Tundo F, Colombo F, Belletti S, Fiorentini C. Autonomic nervous system and paroxysmal atrial fibrillation: A study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation. Eur Heart J 2004;25:1242-8.
86. Kanoupakis EM, Manios EG, Mavrakis HE, Kaleboubas MD, Parthenakis FI, Vardas PE. Relation of autonomic modulation to recurrence of atrial fibrillation following cardioversion. Am J Cardiol 2000;86:954-8.
87. Stein KM, Borer JS, Hochreiter C, Devereux RB, Kligfield P. Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. Am J Cardiol 1994;74:906-11.
88. Frey B, Heinz G, Binder T et al. Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. Am Heart J 1995;129:58-65.
89. Yamada A, Hayano J, Sakata S et al. Reduced ventricular response irregularity is associated with increased mortality in patients with chronic atrial fibrillation. Circulation 2000;102:300-6.
90. Olsson SB, Cai N, Dohnal M, Talwar KK. Noninvasive support for and characterization of multiple intranodal pathways in patients with mitral valve disease and atrial fibrillation. Eur Heart J 1986;7:320-33.
91. Cai NS, Dohnal M, Olsson SB. Methodological aspects of the use of heart rate stratified RR interval histograms in the analysis of atrioventricular conduction during atrial fibrillation. Cardiovasc Res z1987;21: 455-62.
92. Rokas S, Gaitanidou S, Chatzidou S, Agrios N, Stamatelopoulos S. A noninvasive method for the detection of dual atrioventricular node physiology in chronic atrial fibrillation. Am J Cardiol 1999;84:1442-5, A8.
93. Weismuller P, Braunss C, Ranke C, Trappe HJ. Multiple AV nodal pathways with multiple peaks in the RR interval histogram of the Holter monitoring ECG during atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1921-4.
94. Rokas S, Gaitanidou S, Chatzidou S, Pamboucas C, Achtipis D, Stamatelopoulos S. Atrioventricular node modification in patients with chronic atrial fibrillation: Role of morphology of RR interval variation. Circulation 2001;103:2942-8.
95. Ingemansson MP, Carlson J, Olsson SB. Modification of intrinsic AV-nodal properties by magnesium in combination with glucose, insulin, and potassium (GIK) during chronic atrial fibrillation. J Electrocardiol 1998;31:281-92.
96. Olsson SB, Dohnal M, William-Olsson G. Effects of crista terminalis myotomy on the AV-nodal function in atrial fibrillation. The Atrium in Health and Disease. Mount Kisco, New York: Futura Publishing Company, Inc.; 1989.
97. Garrigue S, Tchou PJ, Mazgalev TN. Role of the differential bombardment of atrial inputs to the atrioventricular node as a factor influencing ventricular rate during high atrial rate. Cardiovasc Res 1999;44: 344-55.
98. Tebbenjohanns J, Schumacher B, Korte T, Niehaus M, Pfeiffer D. Bimodal RR interval distribution in chronic atrial fibrillation: Impact of dual atrioventricular nodal physiology on long-term rate control after catheter ablation of the posterior atrionodal input. J Cardiovasc Electrophysiol 2000;11:497-503.
99. Gonzalez MD, Contreras LJ, Cardona F et al. Demonstration of a left atrial input to the atrioventricular node in humans. Circulation 2002;106:2930-4.
100. Billette J, Nadeau RA, Roberge F. Relation between the minimum RR interval during atrial fibrillation and the functional refractory period of the AV junction. Cardiovasc Res 1974;8:347-51.
101. Leung RS, Bowman ME, Diep TM, Lorenzi-Filho G, Floras JS, Bradley TD. Influence of Cheyne-Stokes respiration on ventricular response to atrial fibrillation in heart failure. J Appl Physiol 2005;99:1689-96.
102. Oka T, Nakatsu T, Kusachi S et al. Double-sector Lorenz plot scattering in an R-R interval analysis of patients with chronic atrial fibrillation: Incidence and characteristics of vertices of the double-sector scattering. J Electrocardiol 1998;31:227-35.
103. Van den Berg MP, Van Noord T, Brouwer J et al. Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:1027-33.
104. Bootsma BK, Hoelsen AJ, Strackee J, Meijler FL. Analysis of R-R intervals in patients with atrial fibrillation at rest and during exercise. Circulation 1970;41:783-94.
105. Hayano J, Yamasaki F, Sakata S, Okada A, Mukai S, Fujinami T. Spectral characteristics of ventricular response to atrial fibrillation. Am J Physiol 1997;273:H2811-6.
106. Stein KM, Walden J, Lippman N, Lerman BB. Ventricular response in atrial fibrillation: Random or deterministic? Am J Physiol 1999; 277:H452-8.
107. Meijler FL, Kroneman J, van der Tweel I, Herbschleb JN, Heethaar RM, Borst C. Nonrandom ventricular rhythm in horses with atrial fibrillation and its significance for patients. J Am Coll Cardiol 1984;4:316-23.
108. Rawles JM, Rowland E. Is the pulse in atrial fibrillation irregularly irregular? Br Heart J 1986;56:4-11.
109. Raeder EA. Circadian fluctuations in ventricular response to atrial fibrillation. Am J Cardiol 1990;66:1013-6.
110. Mainardi LT, Matteucci M, Sassi R. On predicting the spontaneous termination of atrial fibrillation episodes using linear and non-linear parameters of ECG signal and RR series. IEEE Comput Cardiol 2004;31:665-9.
111. Vikman S, Makikallio TH, Yli-Mayry S et al. Altered complexity and correlation properties of R-R interval dynamics before the spontaneous onset of paroxysmal atrial fibrillation. Circulation 1999;100: 2079-84.
112. Vikman S, Lindgren K, Makikallio TH, Yli-Mayry S, Airaksinen KE, Huikuri HV. Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation. J Am Coll Cardiol 2005;45:278-84.